TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Vitasora Health ( (AU:VHL) ) has issued an update.
Vitasora Health Limited reported a significant increase in revenue by 256.78% to $3.7 million for the year ending June 2025, despite a rise in net losses to $10.1 million. The integration of Orb Health has resulted in substantial merger synergies, reducing monthly losses by US$148K. The company collected $1.623 million from clients between April and mid-July, improving liquidity. However, no dividends were paid, and the directors do not recommend any for the 2025 financial year.
More about Vitasora Health
Vitasora Health Limited, formerly known as Respiri Limited, operates in the healthcare industry, focusing on providing health solutions through platforms like the Ceras platform. The company has recently expanded its operations through the acquisition of Orb Health, aiming to enhance its market presence and operational efficiency.
YTD Price Performance: -65.06%
Average Trading Volume: 1,712,988
Technical Sentiment Signal: Sell
Current Market Cap: A$49.84M
See more insights into VHL stock on TipRanks’ Stock Analysis page.